• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS).

作者信息

Wald N J, Rodeck C, Hackshaw A K, Walters J, Chitty L, Mackinson A M

机构信息

Department of Environmental and Preventive Medicine, Wolfson Institute of Preventive Medicine, Bart's and the London School of Medicine and Dentistry, London EC1M 6BQ, UK

出版信息

J Med Screen. 2003;10(2):56-104. doi: 10.1258/096914103321824133.

DOI:10.1258/096914103321824133
PMID:14746340
Abstract
摘要

相似文献

1
First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS).孕早期和孕中期唐氏综合征产前筛查：血清、尿液及超声筛查研究（SURUSS）结果
J Med Screen. 2003;10(2):56-104. doi: 10.1258/096914103321824133.
2
SURUSS in perspective.透视下的SURUSS
Semin Perinatol. 2005 Aug;29(4):225-35. doi: 10.1053/j.semperi.2005.05.006.
3
First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS).孕早期和孕中期唐氏综合征产前筛查：血清、尿液及超声筛查研究（SURUSS）结果
Health Technol Assess. 2003;7(11):1-77. doi: 10.3310/hta7110.
4
SURUSS in perspective.透视下的SURUSS。
BJOG. 2004 Jun;111(6):521-31. doi: 10.1111/j.1471-0528.2004.00193.x.
5
An update on antenatal screening for Down's syndrome and specific implications for assisted reproduction pregnancies.唐氏综合征产前筛查的最新情况及对辅助生殖妊娠的特殊影响
Hum Reprod Update. 2006 Sep-Oct;12(5):513-8. doi: 10.1093/humupd/dml021. Epub 2006 May 3.
6
[Prenatal screening for Down's syndrome--moving from the second to the first trimester of pregnancy].[唐氏综合征的产前筛查——从妊娠中期转向妊娠早期]
Harefuah. 1998 Feb 15;134(4):296-301.
7
Feasibility of using plasma rather than serum in first and second trimester multiple marker Down's syndrome screening.在早中期唐氏综合征多重标记物筛查中使用血浆而非血清的可行性。
J Med Screen. 2012 Dec;19(4):164-70. doi: 10.1258/jms.2012.012086. Epub 2012 Dec 31.
8
Ductus venosus pulsatility index as an antenatal screening marker for Down's syndrome: use with the Combined and Integrated tests.静脉导管搏动指数作为唐氏综合征的产前筛查标志物：与联合检测和综合检测联合使用。
J Med Screen. 2009;16(3):112-8. doi: 10.1258/jms.2009.009043.
9
Role of second-trimester ultrasound in screening for Down syndrome.孕中期超声检查在唐氏综合征筛查中的作用。
Ultrasound Obstet Gynecol. 2013 Mar;41(3):241-4. doi: 10.1002/uog.12397.
10
Comparison of different strategies in prenatal screening for Down's syndrome: cost effectiveness analysis of computer simulation.唐氏综合征产前筛查中不同策略的比较：计算机模拟的成本效益分析
BMJ. 2009 Feb 13;338:b138. doi: 10.1136/bmj.b138.

引用本文的文献

1
Screening for pre-eclampsia using pregnancy-associated plasma protein-A or placental growth factor measurements in blood samples collected at 8-14 weeks' gestation.在妊娠8至14周采集的血样中，使用妊娠相关血浆蛋白A或胎盘生长因子检测进行子痫前期筛查。
Ultrasound Obstet Gynecol. 2025 May;65(5):567-574. doi: 10.1002/uog.29204. Epub 2025 Mar 24.
2
Cell-free DNA-based prenatal screening via rolling circle amplification: Identifying and resolving analytic issues.基于游离细胞 DNA 的滚环扩增的产前筛查：分析问题的识别与解决。
J Med Screen. 2023 Dec;30(4):168-174. doi: 10.1177/09691413231173315. Epub 2023 May 17.
3
Application of 4-way decomposition to the analysis of placental-fetal biomarkers as intermediary variables between maternal body mass index and birthweight.
四路分解法在分析胎盘-胎儿生物标志物作为母体体重指数与出生体重之间的中介变量中的应用。
Front Reprod Health. 2022 Dec 5;4:994436. doi: 10.3389/frph.2022.994436. eCollection 2022.
4
A Cost-Effectiveness Analysis of Screening Strategies Involving Non-Invasive Prenatal Testing for Trisomy 21.非侵入性产前检测用于 21 三体综合征筛查策略的成本效果分析。
Front Public Health. 2022 May 31;10:870543. doi: 10.3389/fpubh.2022.870543. eCollection 2022.
5
Prenatal Diagnostic Testing Following High-Risk Result from Serological Screening: Which Shall We Select?血清学筛查高危结果后的产前诊断检测：我们该如何选择？
Int J Womens Health. 2021 Sep 22;13:879-888. doi: 10.2147/IJWH.S324529. eCollection 2021.
6
Optimising classification of Parkinson's disease based on motor, olfactory, neuropsychiatric and sleep features.基于运动、嗅觉、神经精神和睡眠特征优化帕金森病的分类。
NPJ Parkinsons Dis. 2021 Sep 24;7(1):87. doi: 10.1038/s41531-021-00226-2.
7
A toolkit for the application of placental-fetal molecular biomarkers in epidemiologic studies of the fetal origins of chronic disease.用于胎盘 - 胎儿分子生物标志物在慢性疾病胎儿起源流行病学研究中应用的工具包。
Curr Epidemiol Rep. 2021 Mar;8(1):20-31. doi: 10.1007/s40471-020-00258-x. Epub 2020 Dec 28.
8
Sonographic abnormalities in pregnancies conceived following IVF with and without preimplantation genetic testing for aneuploidy (PGT-A).体外受精（IVF）后及胚胎植入前遗传学检测（PGT-A）后妊娠的超声异常。
J Assist Reprod Genet. 2021 Apr;38(4):865-871. doi: 10.1007/s10815-021-02069-5. Epub 2021 Feb 3.
9
Introducing cell-free DNA noninvasive testing in a Down syndrome public health screening program: a budget impact analysis.在唐氏综合征公共卫生筛查项目中引入游离DNA无创检测：预算影响分析
Cost Eff Resour Alloc. 2020 Nov 4;18(1):49. doi: 10.1186/s12962-020-00245-5.
10
Antenatal screening for Down's syndrome: Revised nuchal translucency upper truncation limit due to improved precision of measurement.产前筛查唐氏综合征：由于测量精度提高，修正颈项透明层上截断值。
J Med Screen. 2021 Jun;28(2):88-92. doi: 10.1177/0969141320937321. Epub 2020 Jul 1.